ADIPOQ and breast carcinoma: Studies in breast cancer survivors have demonstrated that weight-loss interventions preferentially decreased leptin levels (-35.6%) and increased the adiponectin-to-leptin ratio (10.6%), independent of changes in absolute adiponectin levels [48].